1st Quarter - Report — EPILEPSY FOUNDATION for EPILEPSY FOUNDATION (2008)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

EPILEPSY FOUNDATION

Client

EPILEPSY FOUNDATION

Income

—

Expenses

$125,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report (this page)	Apr 21, 2008	$125,000	Replaced
1st Quarter - Amendment	Jun 10, 2009	$125,000	Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Civil Rights/Civil Liberties CIV

ADA Restoration Act of 2007 H.R. 3195 S. 1881

Lobbyist	Covered position, as disclosed
ALEXANDRA FINUCANE	Vice President, Legal and Government Affairs
DONNA MELTZER	Senior Government Relations Director
ANGELA OSTROM New	Director, Federal Relations

Contacted: Centers For Disease Control & Prevention (CDC); Justice, Dept of (DOJ); White House Office; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA)

Bills named: S. 1881 (110th), H.R. 3195 (110th)

Budget/Appropriations BUD

Sought report language on Prescription Drug Access Issues in the Argiculture, Rural Development, FDA and Related Issues appropriation bill

Lobbyist	Covered position, as disclosed
ALEXANDRA FINUCANE	Vice President, Legal and Government Affairs
DONNA MELTZER	Senior Government Relations Director
ANGELA OSTROM New	Director, Federal Relations
SHARON SCRIBNER	Sonnenschein

Contacted: Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); SENATE; Justice, Dept of (DOJ); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); White House Office

Veterans VET

H.R. 2818 - Epilepsy Centers of Excellence Act of 2007 S. 2004 - Epilepsy Centers of Excellence Act of 2007

Lobbyist	Covered position, as disclosed
DONNA MELTZER	Senior Government Relations Director
ANGELA OSTROM New	Director, Federal Relations
MARY BETH STANTON	Sonnenschein, Nath & Rosenthal LLP

Contacted: Veterans Affairs, Dept of (VA); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA)

Bills named: S. 2004 (110th), H.R. 2818 (110th)

Health Issues HCR

Medicare and Medicaid Related Issues and Prescription Drug Policy Medicare Policy Reform Prescription Drug Access Issues

Lobbyist	Covered position, as disclosed
ALEXANDRA FINUCANE	Vice President, Legal and Government Affairs
DONNA MELTZER	Senior Government Relations Director
ANGELA OSTROM New	Director, Federal Relations

Contacted: Health Resources & Services Administration (HRSA); SENATE; Veterans Affairs, Dept of (VA); Justice, Dept of (DOJ); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.